Clinical Trial: Optimizing Extended-Duration (XD-) TOMAC Therapy for Restless Legs Syndrome (RLS)

U.S., July 1 -- ClinicalTrials.gov registry received information related to the study (NCT07675109) titled 'Optimizing Extended-Duration (XD-) TOMAC Therapy for Restless Legs Syndrome (RLS)' on June 23.

Brief Summary: This study assesses the tolerability, safety, and impact of an investigational medical device on restless legs syndrome symptoms.

The IRB has established that the investigational device is non-significant risk.

Study Start Date: June 08

Study Type: INTERVENTIONAL

Condition: Restless Legs Syndrome (RLS)

Intervention: DEVICE: Investigational Extended Duration (XD-) TOMAC Therapy

The investigational noninvasive neuromodulation device will be setup by the participant at bedtime and used to provide Extended Duration Tonic ...